Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda source : Spacfeed.com save search
FDA approves Ligand's molluscum contagiosum treatment – Pharmaceutical Technology
Published: 2024-01-08 (Crawled : 10:00) - spacfeed.com
CPT 4 | $95.32 0.28% -0.33% 670K
|
Finance
|
| O: -0.46%
H: 1.63%
C: 1.54%
molluscum fda treatment technology
FDA says not to use certain hip implants from Synovo – Mass Device
Published: 2024-01-03 (Crawled : 23:00) - spacfeed.com
AQU | $10.92 0.55% 5
|
n/a
|
| O: -0.09%
H: 9.11%
C: -0.09%
CPT 4 | $95.32 0.28% -0.33% 670K
|
Finance
|
| O: -0.44%
H: 1.62%
C: 0.44%
ONB A | $15.53 0.32% 0.39% 1M
|
Finance
|
| O: 0.24%
H: 1.75%
C: 0.6%
SIF 4 | $3.08 -2.53% 0.0% 5K
|
Electronic Technology
|
| O: 3.47%
H: 0.41%
C: -4.16%
fda device
Baird Medical wins FDA clearance for microwave ablation system – Medical Device Network
Published: 2023-11-22 (Crawled : 18:00) - spacfeed.com
LNKB | $6.2 -0.96% -1.29% 28K
|
Finance and Insurance
|
| O: 1.0%
H: 0.16%
C: -0.66%
CLAY 4 | $10.66 3.47% 9.2K
|
|
| O: 0.54%
H: 0.0%
C: 0.0%
fda device clearance system network medical
Starton Therapeutics Receives Authorization from the FDA to … – Business Wire
Published: 2023-06-12 (Crawled : 21:00) - spacfeed.com
CFFS | $10.84 -0.73% -0.27% 3
|
n/a
|
| O: -0.19%
H: 0.67%
C: 0.1%
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: 0.05%
H: 0.42%
C: -0.05%
fda business authorization therapeutics
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma – Marketscreener.com
Published: 2023-06-12 (Crawled : 21:00) - spacfeed.com
CFFS | $10.84 -0.73% -0.27% 3
|
n/a
|
| O: -0.19%
H: 0.67%
C: 0.1%
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: 0.05%
H: 0.42%
C: -0.05%
fda authorization trial therapeutics
FDA Guidance Clarifies Approach to Decentralized Clinical Trials – Ropes & Gray LLP
Published: 2023-05-05 (Crawled : 16:00) - spacfeed.com
ESAB | $106.47 -1.04% -0.39% 210K
|
n/a
|
| O: 0.7%
H: 2.81%
C: 2.47%
MODD 4 | $1.7 9.68% 7.46% 75K
|
|
| O: -1.13%
H: 1.84%
C: 1.14%
fda trials
Getting Smarter: FDA Publishes Draft Guidance on Predetermined … – Ropes & Gray LLP
Published: 2023-05-02 (Crawled : 19:00) - spacfeed.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
fda
Spectral MD Holdings, Ltd., an FDA Breakthrough Designated … – PharmiWeb.com
Published: 2023-04-11 (Crawled : 10:00) - spacfeed.com
DMYS | $10.25 0.0% 54K
|
n/a
| Email alert
Add to watchlist
fda
Estrella Biopharma Announces FDA Clearance of IND Application … – PR Newswire Asia
Published: 2023-03-08 (Crawled : 22:00) - spacfeed.com
WEL | $11.42 0.18% 0.0% 1
|
n/a
|
| O: 0.38%
H: 3.83%
C: 0.07%
fda biopharma clearance asia application
Estrella Biopharma Announces FDA Clearance of IND Application … – PR Newswire
Published: 2023-03-08 (Crawled : 22:00) - spacfeed.com
WEL | $11.42 0.18% 0.0% 1
|
n/a
|
| O: 0.38%
H: 3.83%
C: 0.07%
fda biopharma clearance application
Estrella Biopharma Announces FDA Clearance of IND Application … – Yahoo Finance
Published: 2023-03-08 (Crawled : 22:00) - spacfeed.com
WEL | $11.42 0.18% 0.0% 1
|
n/a
|
| O: 0.38%
H: 3.83%
C: 0.07%
fda biopharma clearance application
DiaCarta Receives U.S. FDA Emergency Use Authorization for – GlobeNewswire
Published: 2023-01-12 (Crawled : 14:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.68%
H: 0.29%
C: 0.29%
fda authorization
DiaCarta Receives U.S. FDA Emergency Use Authorization for its … – StreetInsider.com
Published: 2023-01-12 (Crawled : 14:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.68%
H: 0.29%
C: 0.29%
fda authorization
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease … – Yahoo Finance
Published: 2023-01-05 (Crawled : 14:00) - spacfeed.com
ROSE | $11.66 0.0% 3.4K
|
Miscellaneous
|
| O: -0.48%
H: 9.15%
C: 3.08%
LTUM | $0.0379 9.22% 33.16% 85K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
fda rare disease
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance
Published: 2023-01-05 (Crawled : 13:20) - spacfeed.com
LTUM | $0.0379 9.22% 33.16% 85K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
aum302 treatment fda rare designation disease
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.